Literature DB >> 8779133

Asthma and other pulmonary diseases in former elite athletes.

U M Kujala1, S Sarna, J Kaprio, M Koskenvuo.   

Abstract

BACKGROUND: The prevalence of asthma is rising and there are recent reports of increasing asthma rates among top level skiers and runners in the Nordic countries.
METHODS: The lifetime occurrence of pulmonary diseases (asthma, chronic bronchitis, emphysema) and current bronchitis symptoms was compared in former elite male athletes (n = 1282) who represented Finland between 1920 and 1965 at least once in international competitions and controls (n = 777) who, at the age of 20, were classified as healthy and who responded to a questionnaire in 1985. The presence of disease and symptoms was identified from the questionnaire and, in the case of asthma, also from a nationwide reimbursable medication register. The death certificates of the subjects of our original cohort who died between 1936 and 1985 were also investigated to determine the cause of death.
RESULTS: The occurrence of the pulmonary diseases was associated with age, smoking habits, occupational group, and a history of exposure to chemicals. After adjusting for these variables, athletes who participated in mixed sports (odds ratio (OR) 0.46, 95% confidence interval (CI) 0.23 to 0.92) and power sports (OR 0.43, 95% CI 0.21 to 0.87) had lower odds ratios for emphysema, and endurance sports athletes had a lower odds ratio for the presence of at least one pulmonary disease (OR 0.53, 95% CI 0.28 to 0.98) when compared with controls. Athletes also tended to have fewer reimbursable medications for asthma and fewer current symptoms for chronic bronchitis. Between 1936 and 1985 two controls but none of the athletes died of asthma.
CONCLUSIONS: The lifetime occurrence of asthma or other pulmonary diseases is not increased in former elite athletes, and exercise alone, even in a cold environment, did not appear to increase the prevalence of asthma, at least up to the mid 1980s.

Entities:  

Mesh:

Year:  1996        PMID: 8779133      PMCID: PMC1090641          DOI: 10.1136/thx.51.3.288

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

2.  Enhancement of exercise-induced asthma by cold air.

Authors:  R H Strauss; E R McFadden; R H Ingram; J J Jaeger
Journal:  N Engl J Med       Date:  1977-10-06       Impact factor: 91.245

3.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

4.  Increased life expectancy of world class male athletes.

Authors:  S Sarna; T Sahi; M Koskenvuo; J Kaprio
Journal:  Med Sci Sports Exerc       Date:  1993-02       Impact factor: 5.411

5.  Cigarette smoking, use of alcohol, and leisure-time physical activity among same-sexed adult male twins.

Authors:  J Kaprio; M Koskenvuo; S Sarna
Journal:  Prog Clin Biol Res       Date:  1981

6.  Pathogenesis of asthma.

Authors:  E R McFadden
Journal:  J Allergy Clin Immunol       Date:  1984-04       Impact factor: 10.793

7.  Effect of nitrogen dioxide and sulphur dioxide on airway response of mild asthmatic patients to allergen inhalation.

Authors:  J L Devalia; C Rusznak; M J Herdman; C J Trigg; H Tarraf; R J Davies
Journal:  Lancet       Date:  1994-12-17       Impact factor: 79.321

8.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

Authors:  J Kraan; G H Koëter; T W vd Mark; H J Sluiter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

9.  Identification of exercise-induced asthma among intercollegiate athletes.

Authors:  S G Rice; C W Bierman; G G Shapiro; C T Furukawa; W E Pierson
Journal:  Ann Allergy       Date:  1985-12

10.  High prevalence of asthma in cross country skiers.

Authors:  K Larsson; P Ohlsén; L Larsson; P Malmberg; P O Rydström; H Ulriksen
Journal:  BMJ       Date:  1993-11-20
View more
  9 in total

1.  Occurrence of chronic disease in former top-level athletes. Predominance of benefits, risks or selection effects?

Authors:  Urho M Kujala; Pekka Marti; Jaakko Kaprio; Miika Hernelahti; Heikki Tikkanen; Seppo Sarna
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Asthma, outdoor air quality and the Olympic Games.

Authors:  Donald C McKenzie; Louis-Philippe Boulet
Journal:  CMAJ       Date:  2008-08-07       Impact factor: 8.262

3.  Association between type of training and risk of asthma in elite athletes.

Authors:  I J Helenius; H O Tikkanen; T Haahtela
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

Review 4.  Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.

Authors:  J B Langdeau; L P Boulet
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

5.  Physical activity, morbidity and mortality in twins: a 24-year prospective follow-up.

Authors:  Katja Waller; Urho M Kujala; Taina Rantanen; Markku Kauppinen; Karri Silventoinen; Markku Koskenvuo; Jaakko Kaprio
Journal:  Eur J Epidemiol       Date:  2010-08-03       Impact factor: 8.082

Review 6.  Lack of exercise is a major cause of chronic diseases.

Authors:  Frank W Booth; Christian K Roberts; Matthew J Laye
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

7.  Effects of inhaled salbutamol in exercising non-asthmatic athletes.

Authors:  C Goubault; M C Perault; E Leleu; S Bouquet; P Legros; B Vandel; A Denjean
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

8.  Social predictors of adult asthma: a co-twin case-control study.

Authors:  E Huovinen; J Kaprio; L A Laitinen; M Koskenvuo
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

9.  Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.

Authors:  James P Kemp
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.